news + headlines

An established treatment for HIV is being studied for real-world use as prophylaxis in two Canadian trials beginning in late March. Truvada (emtricitabine and tenofovir disoproxil fumarate) is already approved in the United States for the prevention of HIV.
Expanding HIV testing into local hospitals and primary care may not only find more people who have lived with HIV for a long time without knowing it, but may also find more people who have only recently become infected, a pilot study from Vancouver in Canada has found.
Week-long series on PEP. PositiveLite talks with Duncan MacLachlan, the Manager of Community Health Programs at the AIDS Committee of Toronto (ACT), to find out about PEP, its effectiveness and its availability.
To have a meaningful conversation about HIV status, people should... keep it to-the-point and ask the following questions: "When did you last test for HIV? What was the test result?" Equally important is to open minds to reality by remembering that the time of binary HIV statuses is pretty much over.
One in 120 adult Torontonians are living with HIV. Despite advances in treatment, the effects of this disease are still enormous. So where has all the outrage gone?